Contextualizing the Price of Biosimilar Adalimumab Based on Historical Rebates for the Original Formulation of Branded Adalimumab

This cross-sectional study compares recent list and net prices for Humira after rebates with announced prices of interchangeable biosimilar Humira formulations.

Automated summary

This study examines the recent list and net prices of Humira with rebates, comparing them with the announced prices of interchangeable biosimilar formulations of Humira.